ClinicalTrials.gg
Not yet recruitingNCT07941375Updated Nov 17, 2026

Gamified Dual-Task Training for Balance and Exercise Enjoyment in Children With Spastic Cerebral Palsy

An interventional study of Gamified motor-cognitive dual-task training; Other: Routine physiotherapy and Standard single-task balance training in Cerebral Palsy and Spastic, sponsored by Uskudar University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Uskudar University · Not applicable, Interventional, and Treatment

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
11 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 328 studies in Cerebral Palsy with a site in Turkey — 44 open to participants now, 51 under way, none of them phase 3. Cerebral Palsy · Turkey.

Planned enrollment
19th of 190
60 · median 32
Started
2026
with 20 others
No phase
178 of 328
30 open now
Primary completion
2027-02
later than 46 of 50 live
Registered
328th of 328
by date

Among the 328 studies in Cerebral Palsy with a site in Turkey, this one is the 19th largest by planned enrollment of the 190 interventional ones that give a count, is one of 21 that started in 2026, is one of 178 with no phase, reaches primary completion later than 46 of the 50 other live ones, and was the 328th registered.

Cerebral Palsy

1,939 studies on the registry are indexed under Cerebral Palsy; 457 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

44 of the 328 studies in Cerebral Palsy with a site in Turkey are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 269 Cerebral Palsy studies recruiting now, 27 (10%) set no upper age limit and 234 (87%) stop at 75 or younger; 254 take children under 18; 52 take healthy volunteers.

This study: 11 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 328 studies in Cerebral Palsy with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial will investigate whether a low-cost gamified motor-cognitive dual-task training program improves balance and exercise enjoyment more than standard single-task balance training in ambulatory children and adolescents with spastic cerebral palsy aged 11-17 years. Sixty participants attending a special education and rehabilitation center will be randomly assigned to one of two groups. Both groups will continue their routine physiotherapy and receive 30-minute balance training sessions twice a week for 12 weeks. The control group will perform standard single-task balance exercises, while the intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (e.g., counting backwards, naming categories, selecting colored targets) delivered in a game format with low-cost equipment (balls, colored tape, cones, steps). Balance (Pediatric Balance Scale), timed up and go performance under single- and dual-task conditions, gross motor function, walking capacity and exercise enjoyment will be assessed at baseline, after 12 weeks and at a 4-week follow-up by an assessor blinded to group allocation.

Read the detailed description

Background: Balance impairment is a core limitation in children with spastic cerebral palsy (CP). Dual-task training, which combines motor and cognitive tasks, has been shown in meta-analyses to improve balance more than single-task training; however, most programs rely on computer- or virtual-reality-based systems, and the effect of low-cost, device-free gamified dual-task programs on both balance and exercise enjoyment has not been investigated.

Design: Assessor-blinded, two-arm, parallel-group, 1:1 randomized controlled trial with a 12-week intervention and a 4-week follow-up. Participants will be stratified by Gross Motor Function Classification System (GMFCS) level (I-II vs III) and randomized using a computer-generated block randomization list with sequentially numbered, opaque, sealed envelopes prepared by an investigator not involved in treatment or assessment.

Interventions: Both groups will continue routine physiotherapy (2 sessions/week, 40 minutes) at the center and will additionally receive balance training 2 days/week, 30 minutes/session, for 12 weeks. The control group will receive standard single-task balance training (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow and compliant surfaces) with verbal instructions and without concurrent cognitive tasks. The intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (serial subtraction, category naming, letter-number sequencing, stepping or throwing to colored targets according to verbal cues, simple arithmetic) delivered in a game format (colored targets, ball games, points/stars per session, weekly level progression, personal best records). Progression will be applied every 2 weeks along motor (support surface, speed, vision) and, in the intervention group, cognitive (task difficulty) dimensions. All sessions will be delivered by the same physiotherapist according to a written protocol and documented on a session log. No digital devices will be used.

Outcomes: Assessments will be performed at baseline (T0), at the end of the 12-week intervention (T1) and 4 weeks after the end of the intervention (T2) by a second physiotherapist blinded to group allocation. The primary outcome is the Pediatric Balance Scale. Secondary outcomes are the Timed Up and Go test under single- and dual-task (serial subtraction) conditions and the derived dual-task cost, the Gross Motor Function Measure-88 dimensions D and E, the 1-Minute Walk Test and the Physical Activity Enjoyment Scale (PACES-8, Turkish version). All scales have validated Turkish versions.

Sample size: Based on the minimal clinically important difference of the Pediatric Balance Scale in children with CP (approximately 5.8 points, SD approximately 7; effect size d = 0.80), alpha = 0.05 and power = 80%, 26 participants per group are required; allowing for 15% attrition, 30 participants per group (total 60) will be recruited.

Analysis: Intention-to-treat analysis with multiple imputation for missing data. The primary outcome at 12 weeks will be compared between groups by analysis of covariance adjusted for baseline score and GMFCS stratum. Changes across the three time points will be analyzed with linear mixed-effects models including group, time and group × time interaction. Effect sizes (partial eta squared, Cohen d) with 95% confidence intervals will be reported. Significance will be set at p \< 0.05.

03

Conditions studied

  • Cerebral Palsy
  • Spastic

Keywords

  • dual task training
  • balance
  • gamification
  • physiotherapy
04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 11-17 years
  • Diagnosis of spastic (unilateral or bilateral) cerebral palsy confirmed by a pediatric neurologist
  • Gross Motor Function Classification System (GMFCS) level I, II or III
  • Ability to walk independently for at least 10 meters with or without an assistive device
  • Ability to understand and follow two-step verbal commands
  • Receiving physiotherapy at the study center twice a week for at least 3 months
  • Written from the parent/legal guardian and written assent from the participant

Exclusion criteria

Exclusion Criteria:

  • Botulinum toxin injection to the lower extremities within the last 6 months
  • Orthopedic surgery within the last 6 months
  • Uncontrolled epilepsy
  • Uncorrected visual or hearing impairment
  • Severe intellectual disability preventing performance of the cognitive tasks (counting, color discrimination)
  • Participation in another structured balance or exercise program during the study period
  • Uncontrolled cardiac or respiratory disease precluding exercise
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Gamified motor-cognitive dual-task training

    Routine physiotherapy (2 sessions/week, 40 min) plus gamified motor-cognitive dual-task balance training, 2 days/week, 30 min/session, for 12 weeks. Motor balance tasks are combined with simultaneous cognitive tasks and delivered in a game format using low-cost equipment.

    Behavioral: Gamified motor-cognitive dual-task training; Other: Routine physiotherapy · Behavioral: Standard single-task balance training

  • Active comparator
    Standard single-task balance training

    Routine physiotherapy (2 sessions/week, 40 min) plus standard single-task balance training, 2 days/week, 30 min/session, for 12 weeks. Same motor tasks as the experimental arm, delivered with verbal instructions and without concurrent cognitive tasks or game elements.

    Behavioral: Standard single-task balance training

Interventions

  • BehavioralGamified motor-cognitive dual-task training; Other: Routine physiotherapy

    Balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed simultaneously with cognitive tasks (serial subtraction by 3s progressing to 7s, category naming, letter-number sequencing, stepping/throwing to colored targets on verbal cue, simple arithmetic). Delivered in a game format: colored floor and wall targets, ball catching/throwing and target games, points/stars per session, weekly level progression and personal best records. Progression every 2 weeks on motor (support surface, speed, vision) and cognitive (task difficulty) dimensions. Equipment: balls, colored tape, cones, steps; no digital devices. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

  • BehavioralStandard single-task balance training

    The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.

06

What researchers measure

Primary outcomes

  1. Pediatric Balance Scale (PBS) score at 12 weeks

    The PBS is a 14-item functional balance scale for children, each item scored 0-4; total score 0-56, higher scores indicate better balance. Turkish version validated in children with cerebral palsy.

    Time frame: Week 12 (end of intervention)

Secondary outcomes

  1. Change in Pediatric Balance Scale (PBS) score

    Same scale as the primary outcome; change from baseline.

    Time frame: Baseline, Week 12, Week 16 (4-week follow-up)

  2. Timed Up and Go (TUG) test - single task

    Time (seconds) to stand from a chair, walk 3 m, turn, return and sit; mean of three trials. Lower values indicate better functional mobility.

    Time frame: Baseline, Week 12, Week 16

  3. Gross Motor Function Measure-88 (GMFM-88), Dimension D (standing)

    13 items scored 0-3; dimension percentage score 0-100, higher scores indicate better gross motor function. Turkish version validated.

    Time frame: Baseline, Week 12, Week 16

  4. 1-Minute Walk Test (1MWT)

    Distance (meters) walked in 1 minute at a comfortable pace; higher values indicate better walking capacity.

    Time frame: Baseline, Week 12, Week 16

  5. Physical Activity Enjoyment Scale (PACES-8, Turkish version)

    8 items rated on a 7-point Likert scale; total score 8-56, higher scores indicate greater enjoyment of physical activity.

    Time frame: Baseline, Week 12, Week 16

07

Study locations

1 site
  • Bizim Çocuklarımız SPECIAL EDUCATION AND REHABILITATION CENTER
    Istanbul, Güngören, Turkey (Türkiye)
    • Amin Danesfhar · Contact
08

References and documents

Publications

  • Erden A, Acar Arslan E, Dundar B, Topbas M, Cavlak U. Reliability and validity of Turkish version of pediatric balance scale. Acta Neurol Belg. 2021 Jun;121(3):669-675. doi: 10.1007/s13760-020-01302-9. Epub 2020 Feb 19. PubMed 32077065 ↗
  • Szturm T, Parmar ST, Mehta K, Shetty DR, Kanitkar A, Eskicioglu R, Gaonkar N. Game-Based Dual-Task Exercise Program for Children with Cerebral Palsy: Blending Balance, Visuomotor and Cognitive Training: Feasibility Randomized Control Trial. Sensors (Basel). 2022 Jan 19;22(3):761. doi: 10.3390/s22030761. PubMed 35161508 ↗
  • Cortes-Perez I, Castillo-Pintor MLA, Barrionuevo-Berzosa R, Pinar-Lara M, Obrero-Gaitan E, Garcia-Lopez H. Dual-Task Training Interventions for Cerebral Palsy: A Systematic Review and Meta-Analysis of Effects on Postural Balance and Walking Speed. Medicina (Kaunas). 2025 Aug 5;61(8):1415. doi: 10.3390/medicina61081415. PubMed 40870460 ↗

Individual participant data

Plan to share: Undecided — De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Feb 2027, 2 months later.

Of 903 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 2 months is below that.

Counting every sponsor, half of 922 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartEst.
Dec 15, 2026
Primary completionEst.
Feb 20, 2027
CompletionEst.
Feb 20, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941375
Lead sponsor
Uskudar University
Responsible party
Doç.Dr.Ömer Şevgin (Associate Professor, Uskudar University) — Principal investigator
First posted
Nov 17, 2026
Start date
Dec 15, 2026 (estimated)
Primary completion
Feb 20, 2027 (estimated)
Completion
Feb 20, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Ömer Şevgin
Contact
omer.sevgin@uskudar.edu.tr
+905069787535
Amin Danesfhar
study chair · Üsküdar University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion